CAS 873001-54-8
:26-Norolean-8-ene-3,7,29-triol,13-methyl-, 3,29-dibenzoate, (3a,7b,20a)-
Description:
26-Norolean-8-ene-3,7,29-triol, 13-methyl-, 3,29-dibenzoate, (3a,7b,20a)-, with CAS number 873001-54-8, is a complex organic compound characterized by its unique molecular structure, which includes multiple functional groups such as hydroxyl (-OH) and ester (-COOR) groups. This compound is derived from the oleanane triterpenoid family, which is known for its diverse biological activities, including anti-inflammatory and anticancer properties. The presence of the dibenzoate moiety suggests potential applications in medicinal chemistry, particularly in drug formulation or as a bioactive agent. Its stereochemistry, indicated by the specific configuration at various chiral centers, may influence its biological interactions and pharmacokinetics. Additionally, the compound's solubility, stability, and reactivity can be affected by its structural features, making it a subject of interest for further research in both synthetic and natural product chemistry. Overall, this compound exemplifies the complexity and potential utility of triterpenoid derivatives in various scientific fields.
Formula:C44H58O5
Synonyms:- 3,29-Dibenzoyl rarounitriol
- 3,29-O-Dibenzoylmultiflor-8-en-3a,7b,29-triol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
3,29-Dibenzoyl rarounitriol
CAS:3,29-Dibenzoyl karounitriol is a natural product from Trichosanthes kirilowii Maxim.Formula:C44H58O5Purity:95%~99%Molecular weight:666.9433,29-Dibenzoyl Rarounitriol
CAS:<p>3,29-Dibenzoyl karounitriol is a natural product from Trichosanthes kirilowii Maxim.</p>Formula:C44H58O5Purity:97.35% - ≥95%Color and Shape:SolidMolecular weight:666.933,29-Dibenzoyl rarounitriol
CAS:Controlled Product<p>3,29-Dibenzoyl rarounitriol (3,29-DBR) is a quercetin glycoside that has been shown to be an effective inhibitor of the H1 receptor. It prevents the binding of histamine to the H1 receptor on cells, preventing the release of inflammatory compounds such as lysosomal enzymes and prostaglandins. 3,29-DBR has been shown to be a potent inhibitor of terfenadine in both rats and humans. It has also been shown to inhibit other drugs metabolized by cytochrome P450 2D6. In a pharmacokinetic study in rats, 3,29-DBR was found to have a half-life of 5 hours and peak plasma concentrations at 1 hour following oral administration. Pharmacokinetic parameters are dose dependent with Cmax values ranging from 0.5 µg/mL for low doses to 14 µg/mL for high doses.</p>Purity:Min. 95%






